FDA
-
-
-
-
-
-
-
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
-
-
-
-
-
-
-
Cerus Corporation reports preliminary 2025 revenue of $206.1 million
-
-
-
-
-
-
-
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
-
-
-
-
-
-
-
Cerus (CERS) Provides INTERCEPT Red Blood Cell CE Mark Application Update
-
-
-
-
-
-
-
Cerus (CERS) Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device
-
-
-
-
-
-
-
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
-
-
-
-
-
-
-
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
-
323,579 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

